Management of treatment failure in chronic hepatitis B
Fabien Zoulim, Stephen Locarnini
Journal of Hepatology | ELSEVIER | Published : 2012
F.Z. received consulting fees from Gilead Sc, Bristol-Myers Squibb, and Novartis; speaker fees from Gilead Sc and Bristol Myers Squibb; and a research grant to the institution by Roche.S.L. holds patents and received royalties from Melbourne Health; received consulting fees from Evivar Pty Ltd. Gilead Sc, and Bristol-Myers Squibb and other fees from Bristol-Myers Squibb and Merck Sharpe and Dohme Pty Ltd.